Clinical Trials Browser

Prostatic Neoplasms × Ketoconazole × Clear all

NCT00859781 2026-04-08

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Phase 2 Active not recruiting

55 enrolled 11 charts

Prostatic Neoplasms

NCT00019695 2024-03-04

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

Phase 2 Terminated

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn

NCT00027859 2023-06-15

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00030654 2020-10-22

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00460031 2020-07-24

Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

34 enrolled 12 charts

Prostatic Neoplasms

NCT01036594 2020-06-29

Keto/Dex

Phase 2 Completed

32 enrolled 10 charts

Prostatic Neoplasms

NCT00309894 2019-08-05

Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms

NCT02560051 2018-11-28

Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer

Phase 2 Terminated

19 enrolled 25 charts

Prostatic Neoplasms

NCT02494713 2018-11-27

Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

Phase 2 Terminated

4 enrolled 16 charts

Prostatic Neoplasms

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00953576 2018-09-04

KHLAD

Phase 1/2 Terminated

11 enrolled 9 charts

Prostatic Neoplasms

NCT00298155 2018-08-09

TAPS

Phase 2 Completed

35 enrolled 6 charts

Neoplasms, Prostatic Neoplasms

NCT00536991 2017-06-14

Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer

Phase 1/2 Terminated

51 enrolled 11 charts

Prostatic Neoplasms

NCT00895310 2017-03-30

Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy

Phase 2 Completed

30 enrolled 6 charts

Prostatic Neoplasms

NCT00002760 2016-06-28

Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00024167 2016-03-22

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Phase 3 Terminated

265 enrolled 9 charts

Prostatic Neoplasms

NCT00447473 2016-03-17

Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00673127 2015-04-22

KHAD

Phase 2 Completed

57 enrolled 9 charts

Prostatic Neoplasms

NCT00559481 2013-02-01

Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

Phase NA Withdrawn

Prostatic Neoplasms

NCT00014352 2013-01-16

Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms, Thromboembolism

NCT00006371 2012-09-27

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00003084 2012-07-30

Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00870714 2009-03-27

IST 16167

Phase NA Unknown

Prostatic Neoplasms